LONDON (Reuters) - French drugmaker Sanofi's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared to go on sale in the United States, regulators said on Friday.
from
from
ليست هناك تعليقات :
إرسال تعليق